hyderabad the world health organisation who has accepted bharat biotechs expression of interest eoi for the emergency use listing eul of indias first indigenously developed covid19 vaccine covaxin after the company provided the additional data that was sought by the global body the presubmission meeting for covaxin is now planned for june 23 2021 as per the latest who eul guidance document on the status of covid19 vaccines within who eulpq evaluation process once bharat biotech submits the entire covaxin phase3 clinical trials data the dossier will be complete and taken up for review by who a senior bharat biotech official told toi the official had said the company expects the review process for the eul application of covaxin to be taken up in july post submission of the efficacy study data when we get our phase3 efficacy study data then our dossier will be completed and we will submit it to whothey will start reviewing it the official had said weve been in discussions with the who prequalification team and they know exactly what we are doing and what status we are in the official added pointing out that based on the first feedback that the company received from who he indicated that a nod may not be a longdrawn process as the cell line and a majority of its facilities including filling lines have already been audited and approved by who for other vaccines like typhoid polio and rotavirus the good thing about us is that we already have several who prequalified vaccines its not something brand new its not like a new company going for who prequalification its an existing company all our qc qa everything is audited already for our other vaccinesso when they come they make an assessment of everything almost they look at the quality management systems they look at quality control engineering warehouse everything he said the vero cell line that we are using for covaxin is the same vero cell line that we use for the rotavirus vaccine also so who has already seen it and our qc labs our water systems everything has been audited and approved by who for the other vaccines he added bharat biotech had earlier said that it has submitted the application for eul and expects whos stamp of approval for the vaccine in the julyseptember quarter of this year